Merriman Curhan Upgrades Syneron Medical (ELOS) to Buy
More News related to ELOS
- Syneron Medical to Present at Maxim Group Growth Conference
- Syneron(TM) Receives FDA Clearance for Versatile Matrix RF(TM) Fractional Ablative Applicator
- Syneron Receives European CE Mark for Versatile Matrix RF(TM) Fractional Ablative Applicator
- Syneron Medical to Present at UBS Global Life Sciences Conference
- Celebrity Moms' Post-Baby Body Triggers Jealousy, Skepticism in U.S. Moms
Merriman Curhan upgrades Syneron Medical (Nasdaq: ELOS) from Neutral to Buy, citing Q1 earnings report and affirmation of FY revenues.
Syneron Medical Ltd. designs, develops and markets aesthetic medical products based on its electro-optical synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency energy, and optical energy to provide aesthetic medical treatments.
Related Categories
UpgradesStocks Mentioned
-0.06Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
